Moneycontrol PRO
Live Now |Nifty Banker 2.0 - India's First Retail Index Traders Online Conference brought to you by Moneycontrol Pro & Espresso.

business

Ranbaxy to have 30% mkt share for Lipitor: PharmAsiaNews

Vikas Dandekar of PharmAsiaNews.com tells CNBC-TV18 that the US FDA approval for Lipitor is definitely going to be a big positive for Ranbaxy.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections
ISO 27001 - BSI Assurance Mark